SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001213900-21-062344
Filing Date
2021-11-29
Accepted
2021-11-29 16:01:24
Documents
4
Group Members
ABC BETEILIGUNGEN AKTIENGESELLSCHAFTALTECH ADVANCED MATERIALS AGANDREAS DANNERDELPHI UNTERNEHMENSBERATUNG AKTIENGESELLSCHAFTDEUTSCHE BALATON BIOTECH AGHANSJORG PLAGGEMARSHEIDELBERGER BETEILIGUNGSHOLDING AGMING LE SPORTS AGRALPH BIENECKROLF BIRKERTSPARTA A

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 14 TO SCHEDULE 13D ea151427-13da14deutsc_bio.htm SC 13D/A 320679
2 JOINT FILING AGREEMENT ea151427ex99-1_bio.htm EX-99.1 17632
3 AGREEMENT ABOUT THE SETTLEMENT OF LITIGATIONS, DATED NOVEMBER 19, 2021 ea151427ex99-4_bio.htm EX-99.4 15423
4 GRAPHIC img_001.jpg GRAPHIC 23361
  Complete submission text file 0001213900-21-062344.txt   388020
Mailing Address ZIEGELHAUSER LANDSTRABE 1 HEIDELBERG 2M 691924-0
Business Address ZIEGELHAUSER LANDSTRABE 1 HEIDELBERG 2M 691924-0 49 6221 64727-0
DEUTSCHE BALATON AKTIENGESELLSCHAFT (Filed by) CIK: 0001571071 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A

Mailing Address HEMMELRATHER WEG 201 LEVERKUSEN 2M D-51377
Business Address HEMMELRATHER WEG 201 LEVERKUSEN 2M D-51377 011 49 214 876 00
Biofrontera AG (Subject) CIK: 0001712641 (see all company filings)

IRS No.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90509 | Film No.: 211456124
SIC: 2834 Pharmaceutical Preparations